Champions Oncology, Inc. the Company , is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The Company s TumorGraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice. The Company uses this technology, in conjunction with related services, to offer solutions for two consumer groups: Personalized Oncology Solutions POS and Translational Oncology Solutions TOS . POS assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The Company s TOS business offers a technology platform to pharmaceutical and biotechnology companies using proprietary TumorGraft studies, which the Company believes may be predictive of how drugs may perform in clinical settings.
Quote | Champions Oncology Inc. (NASDAQ:CSBR)
Last: | $5.14 |
---|---|
Change Percent: | -5.76% |
Open: | $5.14 |
Close: | $5.14 |
High: | $5.14 |
Low: | $5.14 |
Volume: | 1,158 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Champions Oncology Inc. (NASDAQ:CSBR)
CBL International Limited (BANL) is expected to report for quarter end 2024-03-31 Hilltop Holdings Inc. (HTH) is expected to report $0.24 for Q2 2024 Avidbank Holdings Inc (AVBH) is expected to report $0.68 for Q2 2024 Community West Bancshares (New) Com (CWBC) is expected to report $...
HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on...
Message Board Posts | Champions Oncology Inc. (NASDAQ:CSBR)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CSBR News Article - Champions Oncology Announces the Formation of Corellia AI, a Wholl | whytestocks | investorshangout | 04/17/2023 2:50:53 PM |
whytestocks: $CSBR News Article - Champions Oncology Announces Addition to Board of Directors | whytestocks | investorshangout | 02/22/2021 8:45:53 PM |
whytestocks: $CSBR News Article - Champions Oncology Announces the Launch of Lumin Bioinformatics, I | whytestocks | investorshangout | 11/16/2020 9:55:49 PM |
whytestocks: $CSBR News Article - Champions Oncology Reports Quarterly Revenue of $7.6 Million | whytestocks | investorshangout | 12/16/2019 9:05:44 PM |
whytestocks: $CSBR News Article - Champions Oncology Partners with TransCure bioServices to Expand E | whytestocks | investorshangout | 05/30/2019 3:55:40 PM |
News, Short Squeeze, Breakout and More Instantly...
Champions Oncology Inc. Company Name:
CSBR Stock Symbol:
NASDAQ Market:
Champions Oncology Inc. Website:
CBL International Limited (BANL) is expected to report for quarter end 2024-03-31 Hilltop Holdings Inc. (HTH) is expected to report $0.24 for Q2 2024 Avidbank Holdings Inc (AVBH) is expected to report $0.68 for Q2 2024 Community West Bancshares (New) Com (CWBC) is expected to report $...
HACKENSACK, NJ / ACCESSWIRE / July 11, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the fourth quarter and year-ended April 30, 2024, on...
HACKENSACK, NJ / ACCESSWIRE / June 4, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding f...